Innovation - Articles - Page 7

Prices for state covered drugs in China to be slashed by an average of 61.7%

Dec. 6, 2021

Pharmaceutical companies in China will cut the prices for more than five dozen drugs by an average of 61.7% to get them on the latest version of the country’s National Drug Reimbursement List. The National Healthcare Security Administration released the new list on Dec. 3, 2021. The new list includes 74 new drugs, the vast majority of which are branded products without generic versions in China. Only seven of the new drugs on the list have generic versions.

Opharmic wins grand prize at Asia Pacific Accelerator 2021 program

Oct. 22, 2021

By David Ho

Medical device accelerator Medtech Innovator and the Asia Pacific Medical Technology Association (Apacmed) have selected Opharmic Technology (HK) Ltd. as the grand prize winner of its Asia Pacific Accelerator program. Opharmic has developed a noninvasive ultrasound platform technology for a variety of biomedical applications, with eye drug delivery being one of the key applications.

Medtronic launches Open Innovation Platform in Singapore, along with competition and digital hub

Oct. 22, 2021

By David Ho

With the support of Singapore’s Economic Development Board (EDB), Medtronic plc has launched the Medtronic Open Innovation Platform (OIP) in Singapore to develop med-tech and digital health solutions for Asia Pacific. The company will invest up to $50 million for this venture.

CBO’s H.R. 3 forecast not so sunny for U.S. drug innovation

Aug. 30, 2021

By Mari Serebrov

Sure H.R. 3 could save the U.S. government hundreds of billions of dollars on drug spending, but that savings comes at a long-term cost in innovation that’s higher than the Congressional Budget Office (CBO) initially forecast.

Panakès Partners banks $177M at first close of second fund

July 20, 2021

By Cormac Sheridan

DUBLIN – Panakès Partners SGR SpA has raised €150 million (US$177 million) in a first close of its second fund and is looking to secure a final tally of €180 million by year-end. That would represent more than twice the size of its first fund of €80 million and reflects its move into therapeutics investing.

Med-tech industry concerned that Europe’s HTA agency will not suit its needs

June 28, 2021

By Nuala Moran

LONDON – There has been a lukewarm reception from the industry to the latest developments in the plan to establish a European health technology assessment (HTA) agency, with concerns from pharma that member states will be able to pick and choose whether to apply joint evaluations in national reimbursement and access negotiations.

A U.S. win for 21st century innovation?

June 9, 2021

By Mari Serebrov

Heralded as a potential turning point for U.S. innovation in the 21st century, the U.S. Innovation and Competition Act, S. 1260, is a big step closer to becoming law. The Senate voted 68-32 June 8 to pass the sweeping $250 billion bipartisan bill intended to give the U.S. an edge over China when it comes to innovation and investment in several critical industries, including artificial intelligence, biotechnology and quantum computing.

Chinabio Partnering Forum

Multinational corporations view China as source of innovation and accelerator of digital health

May 12, 2021

By Elise Mak

Multinational players are changing the way they look at China as a source for innovation as it accelerates efforts in areas such as digital health in pursuit of desire to make a global impact. At the Chinabio Partnering Forum, panelists representing Pfizer Inc., Merck & Co. Inc., Sanofi SA and Johnson & Johnson all shared what they have witnessed there and how they’re already tapping China-sourced innovations.

2021 China Pharmaceutical Innovation 100 Summit

China launches policies to encourage innovation, but pricing and payment remain pain points

April 13, 2021

By Elise Mak

SHANGHAI – China’s regulatory environment has evolved to encourage drug innovation, but despite remarkable progress, mounting pricing pressure from the government and a weak insurance sector remain as barriers.

EC launches council to make money out of science

March 18, 2021

By Mari Serebrov

Combining research on emerging technologies with an accelerator program and a dedicated equity fund, the European Commission (EC) launched the European Innovation Council March 18 to invest in promising research and to scale up innovative startups and small- and medium-size businesses.